Delivery Order SPE2DB22D2206-SPE2DB25FJM91
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a $2,922.80 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Qsymia 3.75 mg-23 mg capsules in a 30-count package. This is a firm fixed-price delivery order with an ultimate completion date of August 12, 2025, and no set-aside designation was utilized. The award represents a competitive procurement action through an open competition process. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp for $1,225.31 on June 5, 2025, for the supply of Qsymia 3.75 mg-23 mg capsules (30-count package). This is a non-set-aside competitive award with an ultimate completion date of June 6, 2025, to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 13, 2025, for the supply of Qsymia 15 mg-92 mg capsules (30-count units) with a ceiling value of $1,732.83. This firm fixed-price delivery order, with an ultimate completion date of May 14, 2025, represents a pediatric or standard-dose pharmaceutical supply requirement fulfilled through AmerisourceBergen's existing Indefinite Delivery Contract vehicle with DLA Troop Support Medical. The contract carries...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Qsymia 15mg-92mg in 30-count packages, with a ceiling value of $2,738.80. This is a firm fixed price delivery order with no set-aside designation, utilizing competitive procurement procedures. The contract is performable in Conshohocken, Pennsylvania, with an ultimate completion date of June 17, 2025, and represents a child delivery order under a larger...
- This delivery order awards AmerisourceBergen Drug Corp $1,274.50 for the supply of Qsymia 7.5 mg-46 mg capsules (30-count) under a firm fixed-price contract. The award was made on August 13, 2025, with an ultimate completion date of August 14, 2025, and represents a non-competitive, non-set-aside award through the Defense Logistics Agency's Medical Supply Chain. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Qsymia is a combination phentermine and...
- The Defense Logistics Agency awarded a $1,646.10 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Qsymia 7.5 mg-46 mg capsules (30-count) under contract 4569035131. The delivery order, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a non-set-aside, competitively awarded procurement. Performance will be executed from the vendor's Conshohocken, Pennsylvania location, which serves as the company's corporate office and...
- The Defense Logistics Agency awarded a $1,810.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Qsymia 11.25 mg-69 mg capsules (30-count), a prescription weight management medication. The order was competitively awarded with no set-aside designation and is scheduled for completion by August 18, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $4,444.52 to AmerisourceBergen Drug Corp for the supply of Qsymia 15 mg–92 mg capsules (30-count) on September 16, 2025, with completion targeted for September 17, 2025. This firm fixed-price delivery order utilizes no set-aside designation and represents a competitively awarded transaction under AmerisourceBergen's existing contract vehicle with DLA. The product will be performed at the contractor's location in Conshohocken,...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of QSYMIA 15 mg-92 mg capsules (30-count units) with a firm fixed price ceiling value of $1,643.28. This is a non-set-aside, competitively awarded contract with an ultimate completion date of July 22, 2025, and represents a child delivery order under AmerisourceBergen's larger contract vehicle. The place of performance is located in Conshohocken,...
- The Defense Logistics Agency awarded a $1,013.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Qsymia 7.5 mg-46 mg capsules (30-count units). This is a non-set-aside, competitively awarded contract with an ultimate completion date of July 31, 2025, and performance to be fulfilled at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJM91Delivery Order
This delivery order, awarded on August 20, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides for the supply of Qsymia 11.25 mg-69 mg capsules (30-count unit) with a firm fixed price ceiling value of $2,037.36. The order is scheduled for completion by August 21, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This award was not designated as a set-aside contract and was competitively awarded under an existing contract vehicle. This delivery order represents a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen serves the Department of Defense healthcare systems, including the Defense Health Agency and other military medical supply chains. The Qsymia pharmaceutical product supplied under this order supports the company's extensive portfolio of medications delivered to federal military and veteran healthcare systems across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 8/20/25 |